NOAC Portuguese Real World Study

Stopped Withdrawn due to COVID19 pandemic. Several delays affected this study, therefore company decided to not conduct the study. It was cancelled prior to any enrollment.

Conditions

• Stroke
• Systemic Embolism
• Major Bleeding

Interventions

• DRUG: Apixaban
• DRUG: dabigatran
• DRUG: rivaroxaban
• DRUG: VKAs

Sponsor

Pfizer